Delivery Order SPE2DB20D1100-SPE2DB25FA0N0

Award Date 1/14/25
Potential Completion Date 1/15/25
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,659.13, is a Firm Fixed Price Delivery Order for the supply of Diazepam 10 mg/2 ml syringes. The contract has an ultimate completion date of January 31, 2025. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,247.46 firm fixed-price delivery order contract is for the supply of Diazepam 10 mg/2 ml syringes. The contract has an ultimate completion date of December 19, 2024 and is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This federal contract award, valued at $7,948.29, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Diazepam 5mg/ml injectable solution in packages of 10. This delivery order falls under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, worth up to $999,999,999 through December 2025, for providing a comprehensive range...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,691,167 units of Diazepam 10 mg/2 ml syringes. The order has a completion date of February 20, 2024 and a potential value of $1,188.45. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) they hold with DLA valued at up to...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Diazepam 10mg rectal medication to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $2,112.83 and an ultimate completion date of August 29, 2024. The contract is a delivery order issued under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award to Amerisourcebergen Drug Corp provides for the delivery of Diazepam 5mg/ml injectable solutions. The $5,122.34 firm fixed price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, on September 5, 2024, with a completion date of September 6, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at up to $999,999,999 through December...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $5,393.84 and a completion date of October 16, 2023. It is a firm fixed-price contract for the delivery of 10 mg/2 mL diazepam syringes. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,766.59 firm fixed-price delivery order is for the supply of Diazepam 5mg/ml Vials in lots of 10, with a completion date of August 13, 2024. The contract is not set aside for any specific business category. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Diazepam 5mg/ml vials. The contract is a Delivery Order under a Firm Fixed Price contract type, with a ceiling value of $2,916.21 and a performance period ending on July 17, 2024. The contracting agency is the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. Amerisourcebergen has been awarded multiple Indefinite Delivery Contracts (IDCs) with the DLA and other...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of 4,565,536,715 units of Diazepam 50 mg/10 ml vials, at a total ceiling value of $1,655.36. The contract is a Firm Fixed Price type with an ultimate completion date of August 23, 2024. Amerisourcebergen, through its corporate office division, has been awarded this contract to provide this...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FA0N0
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Diazepam 10 mg/2 ml syringes. The contract has a ceiling value of $2,015.60 and a completion date of January 15, 2025. It is structured as a delivery order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have any set-aside designation, indicating open competition.

Generated 4/16/25, 5:49 PM